Sam Brusco, Associate Editor04.20.23
GE HealthCare has earned U.S. Food and Drug Administration (FDA) 510(k) clearance for its CARESCAPE Canvas patient monitoring platform. Along with CARESCAPE ONE, Canvas is part of an adaptable ecosystem that can scale up and down monitoring capabilities based on each patient’s acuity.
“As patient acuity and disease trends change rapidly, adaptability in the hospital setting is becoming more important. We look for ways to improve the care experience by delivering quality clinical measurements where and when they are needed, giving care providers the information they need to make the best possible clinical decisions,” Dr. Roland Schrewe, head of PICU, University of Frankfurt, told the press. “GE HealthCare’s CARESCAPE Canvas provides a precise, standardized and flexible patient monitoring solution that adapts to patient needs with the ease of switching out a cable.”
CARESCAPE Canvas is a FlexAcuity solution with smart parameter tech. It leverages micromodules that connect with standardized medical USB tech so cables can simply be added or disconnected for various configurations. It also has flexible, easily configurable software and interchangeable frames for advanced parameters.
“This new monitoring ecosystem has the potential for a hospital to have one single unified approach to patient monitoring that can be easily tailored for each patient,” said Neal Sandy, general manager, monitoring solutions, GE HealthCare. “GE HealthCare is committed to offering flexible solutions that enable care teams to focus on the patient, not the technology. CARESCAPE Canvas’ innovative approach, where software and patient parameters can change in a very nimble manner, enable a standardized ecosystem that can adapt to changing healthcare needs.”
The Canvas bedside monitor was developed and tested with the rest of GE HealthCare’s ecosystem, including both current and prior version of devices. The backward compatibility lets healthcare systems upgrade to latest capabilities at their own pace.
According to the company, CARESCAPE Canvas also has a 53% reduction in packaging volume, 48% reduction in packaging weight compared to a previous generation monitor, and 25% reduction in energy consumption compared to previous models. It was approved in the EU in June 2022.
“As patient acuity and disease trends change rapidly, adaptability in the hospital setting is becoming more important. We look for ways to improve the care experience by delivering quality clinical measurements where and when they are needed, giving care providers the information they need to make the best possible clinical decisions,” Dr. Roland Schrewe, head of PICU, University of Frankfurt, told the press. “GE HealthCare’s CARESCAPE Canvas provides a precise, standardized and flexible patient monitoring solution that adapts to patient needs with the ease of switching out a cable.”
CARESCAPE Canvas is a FlexAcuity solution with smart parameter tech. It leverages micromodules that connect with standardized medical USB tech so cables can simply be added or disconnected for various configurations. It also has flexible, easily configurable software and interchangeable frames for advanced parameters.
“This new monitoring ecosystem has the potential for a hospital to have one single unified approach to patient monitoring that can be easily tailored for each patient,” said Neal Sandy, general manager, monitoring solutions, GE HealthCare. “GE HealthCare is committed to offering flexible solutions that enable care teams to focus on the patient, not the technology. CARESCAPE Canvas’ innovative approach, where software and patient parameters can change in a very nimble manner, enable a standardized ecosystem that can adapt to changing healthcare needs.”
The Canvas bedside monitor was developed and tested with the rest of GE HealthCare’s ecosystem, including both current and prior version of devices. The backward compatibility lets healthcare systems upgrade to latest capabilities at their own pace.
According to the company, CARESCAPE Canvas also has a 53% reduction in packaging volume, 48% reduction in packaging weight compared to a previous generation monitor, and 25% reduction in energy consumption compared to previous models. It was approved in the EU in June 2022.